Clinical trial

Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

NCT02078570

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2014-03-01

PhaseN/A

Study timeline

Study start (unknown)2014-03-01Date precision: month

Registry last updated2016-09-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Sponsors & collaborators

Provista Diagnostics, Inclead sponsor

Mapped research locations

DetroitMichigan, United States2 ClevelandOhio, United States1 San DiegoCalifornia, United States1 PhoenixArizona, United States1 Oklahoma CityOklahoma, United States1 RochesterMinnesota, United States1 SacramentoCalifornia, United States1 ProvidenceRhode Island, United States1 ScottsdaleArizona, United States1 Sioux FallsSouth Dakota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02078570 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.